{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:06:15Z","timestamp":1789628775823,"version":"build-2803163510"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T00:00:00Z","timestamp":1785024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["HL160966"],"award-info":[{"award-number":["HL160966"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology Plus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jmccpl.2026.100859","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:20:25Z","timestamp":1785482425000},"page":"100859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy"],"prefix":"10.1016","volume":"17","author":[{"given":"Jan M.","family":"Federspiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Lee","family":"Medarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek P.","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Renato","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maicon","family":"Landim-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmccpl.2026.100859_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary artery risk development in (Young) adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0010","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0015","first-page":"e558","article-title":"AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0020","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC)","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0025","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/heart.84.5.476","article-title":"Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease","volume":"84","author":"Varnava","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.amjmed.2003.10.012","article-title":"Hypertrophic cardiomyopathy: an important global disease","volume":"116","author":"Maron","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0040","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jchf.2023.04.018","article-title":"Cardiac myosin inhibitors for managing obstructive hypertrophic cardiomyopathy: JACC: heart failure state-of-the-art review","volume":"11","author":"Ostrominski","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0050","first-page":"47","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"116","author":"Batzner","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijcard.2021.01.032","article-title":"Surgical myectomy in HOCM: still gold standard for septal reduction?","volume":"331","author":"Seggewiss","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ehf2.13750","article-title":"Age-related survival after alcohol septal ablation in hypertrophic obstructive cardiomyopathy","volume":"9","author":"Batzner","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0065","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ehjci\/jead236","article-title":"Non-invasive estimation of left ventricular systolic peak pressure: a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy","volume":"25","author":"Batzner","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.102337","article-title":"Translational insights into myocardial deformation and fibrosis in hypertrophic cardiomyopathy using diffusion tensor MRI","volume":"4","author":"Laghzali","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJM197701202960303","article-title":"Isometric cardiac contraction. A possible cause of the disorganized myocardial pattern of idiopathic hypertrophic subaortic stenosis","volume":"296","author":"Bulkley","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrcardio.2009.9","article-title":"Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis","volume":"6","author":"Olivotto","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep27714","article-title":"The embryological basis of subclinical hypertrophic cardiomyopathy","volume":"6","author":"Captur","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0090","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011435","article-title":"Retrofitting the heart: explaining the enigmatic septal thickening in hypertrophic cardiomyopathy","volume":"17","author":"Federspiel","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ajmg.c.31778","article-title":"Development of the human heart","volume":"184","author":"Buijtendijk","year":"2020","journal-title":"Am J Med Genet C: Semin Med Genet"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0100","series-title":"Cardiac Development","author":"Kirby","year":"2007"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03153-x","article-title":"A pictorial account of the human embryonic heart between 3.5 and 8 weeks of development","volume":"5","author":"Hikspoors","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0110","first-page":"1","article-title":"A bioelectrical phase transition patterns the first vertebrate heartbeats","author":"Jia","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12565-009-0023-4","article-title":"Molecular embryology for an understanding of congenital heart diseases","volume":"84","author":"Yamagishi","year":"2009","journal-title":"Anat Sci Int"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.acvd.2008.06.020","article-title":"Genetics and embryological mechanisms of congenital heart diseases","volume":"102","author":"Bajolle","year":"2009","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0125","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1253\/circj.CJ-11-0636","article-title":"A decade of advances in the molecular embryology and genetics underlying congenital heart defects","volume":"75","author":"Kodo","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1213\/ANE.0000000000001451","article-title":"Cardiac embryology and molecular mechanisms of congenital heart disease: a primer for anesthesiologists","volume":"123","author":"Kloesel","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092903","article-title":"A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes","volume":"9","author":"Cox","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0140","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/hc4901.100526","article-title":"Metabolic gene expression in fetal and failing human heart","volume":"104","author":"Razeghi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/joim.13094","article-title":"Cardiac foetal reprogramming: a tool to exploit novel treatment targets for the failing heart","volume":"288","author":"van der Pol","year":"2020","journal-title":"J Intern Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0150","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2013.07.023","article-title":"Regulation of fetal gene expression in heart failure","volume":"1832","author":"Dirkx","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0155","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/3253","article-title":"Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy","volume":"4","author":"Depre","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221244120","article-title":"Cardiac troponin T N-domain variant destabilizes the actin interface resulting in disturbed myofilament function","volume":"120","author":"Landim-Vieira","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0165","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1039\/D1SC01886H","article-title":"Anomalous structural dynamics of minimally frustrated residues in cardiac troponin C triggers hypertrophic cardiomyopathy","volume":"12","author":"Marques","year":"2021","journal-title":"Chem Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10974-020-09592-5","article-title":"A comprehensive guide to genetic variants and post-translational modifications of cardiac troponin C","volume":"42","author":"Reinoso","year":"2021","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0175","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS2024: Heart failure epidemiology and outcomes statistics an updated 2024 report from the Heart Failure Society of America","volume":"31","author":"Bozkurt","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0180","first-page":"36","article-title":"The genetics of hypertrophic cardiomyopathy","author":"Akhtar","year":"2018","journal-title":"Glob Cardiol Sci Pract"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0185","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1161\/CIRCULATIONAHA.121.053527","article-title":"Time to think differently about sarcomere-negative hypertrophic cardiomyopathy","volume":"143","author":"Watkins","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric human cardiomyopathy registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0195","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0200","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2020.10.006","article-title":"Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes","volume":"150","author":"Schuldt","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceca.2018.04.009","article-title":"CRISPR\/Cas9 gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling","volume":"73","author":"Wei","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0210","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1161\/CIRCULATIONAHA.120.047999","article-title":"Development of a cardiac sarcomere functional genomics platform to enable scalable interrogation of human TNNT2 variants","volume":"142","author":"Pettinato","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/CIRCRESAHA.122.321951","article-title":"IPSC-based modeling of variable clinical presentation in hypertrophic cardiomyopathy","volume":"133","author":"Escrib\u00e1","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0220","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13287-022-02905-0","article-title":"Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells","volume":"13","author":"Li","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0225","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJMra2413445","article-title":"Hypertrophic cardiomyopathy","volume":"393","author":"Braunwald","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0230","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.jacc.2020.03.064","article-title":"Evaluation of Mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy","volume":"75","author":"Ho","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0235","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/0735-1097(93)90196-8","article-title":"An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy","volume":"22","author":"Sherrid","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0245","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/ejcts\/ezr232","article-title":"Modern management of systolic anterior motion of the mitral valve","volume":"41","author":"Ibrahim","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0250","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jacc.2019.08.1057","article-title":"Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry","volume":"74","author":"Neubauer","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.123.323173","article-title":"Exploring the connection between relaxed myosin states and the Anrep effect","volume":"134","author":"Sequeira","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0260","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1074\/jbc.RA118.002081","article-title":"Hypertrophic cardiomyopathy mutations increase myofilament Ca2+ buffering, alter intracellular Ca2+ handling, and stimulate Ca2+\u2212dependent signaling","volume":"293","author":"Robinson","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0265","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1093\/cvr\/cvy147","article-title":"Metabolic changes in hypertrophic cardiomyopathies: scientific update from the working Group of Myocardial Function of the European Society of Cardiology","volume":"114","author":"van der Velden","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0270","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0735-1097(02)03009-7","article-title":"Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy","volume":"41","author":"Crilley","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0275","article-title":"Mechano-energetic uncoupling in hypertrophic cardiomyopathy: pathophysiological mechanisms and therapeutic opportunities","volume":"4","author":"Sequeira","year":"2023","journal-title":"J Mol Cell Cardiol Plus"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0280","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvt119","article-title":"Mutations in MYH7 reduce the force generating capacity of sarcomeres in human familial hypertrophic cardiomyopathy","volume":"99","author":"Witjas-Paalberends","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0285","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1074\/jbc.M006746200","article-title":"Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation","volume":"276","author":"Miller","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0290","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1161\/CIRCULATIONAHA.108.838672","article-title":"Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction","volume":"119","author":"van Dijk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0295","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.111.300436","article-title":"Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations","volume":"112","author":"Sequeira","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2023.102822","article-title":"Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation","volume":"117","author":"Guo","year":"2024","journal-title":"Cell Calcium"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0305","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004133","article-title":"Sex differences at the time of myectomy in hypertrophic cardiomyopathy","volume":"11","author":"Nijenkamp","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0310","article-title":"Suppression of lusitropy as a disease mechanism in cardiomyopathies","volume":"9","author":"Marston","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0315","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1074\/jbc.M111.294306","article-title":"Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy","volume":"287","author":"Wang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0320","doi-asserted-by":"crossref","first-page":"23097","DOI":"10.1074\/jbc.M114.561472","article-title":"Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy","volume":"289","author":"Dweck","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0325","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1042\/BST20140324","article-title":"The myosin mesa and a possible unifying hypothesis for the molecular basis of human hypertrophic cardiomyopathy","volume":"43","author":"Spudich","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0330","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00424-019-02259-2","article-title":"Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations","volume":"471","author":"Spudich","year":"2019","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0335","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1113\/jphysiol.2014.274571","article-title":"Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation","volume":"592","author":"Witjas-Paalberends","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0340","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1093\/cvr\/cvu127","article-title":"Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations","volume":"103","author":"Witjas-Paalberends","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0345","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009521","article-title":"Defects in the proteome and metabolome in human hypertrophic cardiomyopathy","volume":"15","author":"Previs","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0350","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000126898.95550.31","article-title":"Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening","volume":"94","author":"Palmer","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0355","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.yjmcc.2018.12.003","article-title":"MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy","volume":"127","author":"O\u2019Leary","year":"2019","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0360","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00424-013-1391-0","article-title":"Preserved cross-bridge kinetics in human hypertrophic cardiomyopathy patients with MYBPC3 mutations","volume":"466","author":"van Dijk","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0365","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.122.321956","article-title":"Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM","volume":"132","author":"Pioner","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.00959","article-title":"Maturation of cardiac energy metabolism during perinatal development","volume":"9","author":"Piquereau","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0375","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4070\/kcj.2021.0153","article-title":"Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation","volume":"51","author":"Seok","year":"2021","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.bioeng.3.1.1","article-title":"Biomechanics of cardiovascular development","volume":"3","author":"Taber","year":"2001","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0385","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/heartjnl-2015-308348","article-title":"Cellular and molecular basis of RV hypertrophy in congenital heart disease","volume":"102","author":"Iacobazzi","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0390","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1089\/ars.2017.7236","article-title":"Hypertrophic cardiomyopathy: a vicious cycle triggered by sarcomere mutations and secondary disease hits","volume":"31","author":"Wijnker","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0395","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","article-title":"Role of oxidative stress in cardiac hypertrophy and remodeling","volume":"49","author":"Takimoto","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0400","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cmet.2015.07.008","article-title":"Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure","volume":"22","author":"Nickel","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0405","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.yjmcc.2014.03.011","article-title":"Mitochondrial reactive oxygen species production and elimination","volume":"73","author":"Nickel","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0410","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy","volume":"144","author":"Ranjbarvaziri","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0415","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.CIR.0000023900.58293.FE","article-title":"Fetal cardiomyopathies","volume":"106","author":"Pedra","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0420","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jchf.2014.02.010","article-title":"Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life","volume":"2","author":"Weber","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0425","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.117.030730","article-title":"Is load-induced ventricular hypertrophy ever compensatory?","volume":"136","author":"Schiattarella","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0430","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s10439-020-02683-x","article-title":"Biomechanics of human fetal hearts with critical aortic stenosis","volume":"49","author":"Ong","year":"2021","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-023-05013-8","article-title":"Molecular and cellular evidence for the impact of a hypertrophic cardiomyopathy-associated RAF1 variant on the structure and function of contractile machinery in bioartificial cardiac tissues","volume":"6","author":"Nakhaei-Rad","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0440","article-title":"Prediction of fetal hypertrophic cardiomyopathy in diabetic pregnancies compared with postnatal outcome","volume":"8","author":"Elmekkawi","year":"2015","journal-title":"Clin Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0445","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/pr.2016.24","article-title":"Intrauterine growth restriction: impact on cardiovascular development and function throughout infancy","volume":"79","author":"Cohen","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0450","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/01.CIR.94.4.667","article-title":"Control mechanisms for physiological hypertrophy of pregnancy","volume":"94","author":"Mone","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0455","doi-asserted-by":"crossref","first-page":"H622","DOI":"10.1152\/ajpheart.00277.2024","article-title":"The role of mechanosignaling in the control of myocardial mass","volume":"328","author":"Landim-Vieira","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0460","article-title":"Definitional challenges in understanding hypertrophic cardiomyopathy","volume":"14","author":"Federspiel","year":"2024","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0465","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239773","article-title":"Ultrasound and genetic detection of fetal hypertrophic cardiomyopathy in second trimester of pregnancy","volume":"14","author":"Soares","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0470","first-page":"4","article-title":"Hypertrophic cardiomyopathy due to mitochondrial disease: prenatal diagnosis, management, and outcome","volume":"2013","author":"Garc\u00eda-D\u00edaz","year":"2013","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0475","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00246-015-1250-1","article-title":"Intrauterine treatment of a fetus with familial hypertrophic cardiomyopathy secondary to MYH7 mutation","volume":"36","author":"Hill","year":"2015","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0480","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.2174\/138161210793176428","article-title":"Diagnosis and prognosis of fetal cardiomyopathies: a review","volume":"16","author":"Mongiov\u00ec","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0485","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1017\/S1047951101000956","article-title":"Fetal myocardial hypertrophy in an experimental model of gestational diabetes","volume":"11","author":"Menezes","year":"2001","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0490","doi-asserted-by":"crossref","first-page":"F351","DOI":"10.1136\/archdischild-2012-302546","article-title":"Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism","volume":"98","author":"Huang","year":"2013","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0495","first-page":"3","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy: patterns and implications","volume":"61","author":"Keramida","year":"2020","journal-title":"Hell J Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0500","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/clc.4960240102","article-title":"Right ventricular involvement in hypertrophic cardiomyopathy: a case report and literature review","volume":"24","author":"Mozaffarian","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0505","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2559.2004.01835.x","article-title":"The pathology of hypertrophic cardiomyopathy","volume":"44","author":"Hughes","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0510","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318413121","article-title":"Incomplete-penetrant hypertrophic cardiomyopathy MYH7 G256E mutation causes hypercontractility and elevated mitochondrial respiration","volume":"121","author":"Lee","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0515","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.125.074120","article-title":"Hypercontractility and oxidative stress drive creatine kinase dysfunction in hypertrophic cardiomyopathy","author":"Xu","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0520","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ceb.2020.03.001","article-title":"The role of the cell nucleus in mechanotransduction","volume":"63","author":"Janota","year":"2020","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113901","article-title":"Phenotype specific nuclear lamina remodeling in hiPSC derived cardiomyocytes bearing TNNT2 sarcomeric variants","volume":"28","author":"Coscarella","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0530","doi-asserted-by":"crossref","first-page":"88a","DOI":"10.1016\/j.bpj.2022.11.679","article-title":"Hypercontractility by hypertrophic cardiomyopathy mutant iPSC-CMs induces hippo-yap activation through enhanced nuclear deformation","volume":"122","author":"Chirikian","year":"2023","journal-title":"Biophys J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0535","article-title":"YAP dysregulation triggers hypertrophy by CCN2 secretion and TGF\u03b2 uptake in human pluripotent stem cell-derived cardiomyocytes","author":"Chirikian","year":"2024","journal-title":"bioRxivorg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0540","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41392-024-02069-8","article-title":"The molecular mechanisms of cardiac development and related diseases","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0545","article-title":"A comprehensive assessment of cardiomyopathies through cardiovascular magnetic resonance: focus on the pediatric population","volume":"12","author":"Baessato","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0550","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66582","article-title":"The Ca2+\u2212activated cation channel TRPM4 is a positive regulator of pressure overload-induced cardiac hypertrophy","volume":"10","author":"Guo","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0555","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/CIRCRESAHA.123.322798","article-title":"PIEZO ion channels in cardiovascular functions and diseases","volume":"134","author":"Coste","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0560","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1002\/jcp.27791","article-title":"Ranolazine prevents pressure overload-induced cardiac hypertrophy and heart failure by restoring aberrant Na+ and Ca2+ handling: NIE et al","volume":"234","author":"Nie","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0565","article-title":"Harnessing fetal and adult genetic reprograming for therapy of heart disease","volume":"1","author":"Nandi","year":"2015","journal-title":"J Nat Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0570","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJM197710272971704","article-title":"Insulin receptors in the newborn. Increase in receptor affinity and number","volume":"297","author":"Thorsson","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0575","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0022-3476(80)80862-6","article-title":"Cardiac septal hypertrophy in hyperinsulinemic infants","volume":"96","author":"Breitweser","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0580","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/jpem-2011-0448","article-title":"A novel mutation of the insulin receptor gene in a preterm infant with Donohue syndrome and heart failure","volume":"25","author":"Nobile","year":"2012","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0585","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000509837","article-title":"Intrauterine growth restriction and hypertrophic cardiomyopathy as prenatal ultrasound findings in a case of leprechaunism","volume":"11","author":"Perge","year":"2020","journal-title":"Mol Syndromol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0590","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/01.RES.0000059562.91384.1A","article-title":"Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+\u2212dependent action potential remodeling","volume":"92","author":"Knollmann","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0595","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.112.270041","article-title":"Myofilament ca sensitization increases cytosolic ca binding affinity, alters intracellular ca homeostasis, and causes pause-dependent ca-triggered arrhythmia","volume":"111","author":"Schober","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0600","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/CIRCRESAHA.113.301055","article-title":"Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments","volume":"112","author":"Huke","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0605","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0610","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1113\/jphysiol.2010.189670","article-title":"Postnatal development of mouse heart: formation of energetic microdomains","volume":"588","author":"Piquereau","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0615","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1254\/jphs.13099FP","article-title":"Developmental changes in excitation-contraction mechanisms of the mouse ventricular myocardium as revealed by functional and confocal imaging analyses","volume":"123","author":"Hamaguchi","year":"2013","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0620","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.112.134932","article-title":"Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy","volume":"127","author":"Coppini","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0625","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yjmcc.2021.04.009","article-title":"Translational investigation of electrophysiology in hypertrophic cardiomyopathy","volume":"157","author":"Flenner","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0630","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/physrev.00014.2006","article-title":"Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation","volume":"87","author":"Nattel","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0635","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.yjmcc.2009.07.016","article-title":"Ion-channel mRNA-expression profiling: insights into cardiac remodeling and arrhythmic substrates","volume":"48","author":"Nattel","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0640","doi-asserted-by":"crossref","first-page":"s95","DOI":"10.1016\/S0378-4274(03)90348-1","article-title":"349 hallmarks of ion channel gene expression in end-stage heart failure","volume":"144","author":"Borlak","year":"2003","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0645","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1096\/fj.02-0889com","article-title":"Hallmarks of ion channel gene expression in end-stage heart failure","volume":"17","author":"Borlak","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0650","first-page":"20210325","article-title":"Sarcomere maturation: function acquisition, molecular mechanism, and interplay with other organelles","volume":"377","author":"Ahmed","year":"2022","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0655","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2002.036509","article-title":"Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart","volume":"548","author":"Siedner","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0660","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41569-025-01205-3","article-title":"Transcriptional regulation in heart development, disease and regeneration: reassessing the fetal gene hypothesis","volume":"23","author":"Porrello","year":"2026","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0665","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1172\/JCI114351","article-title":"Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches","volume":"84","author":"Nadal-Ginard","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0670","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2013.05.024","article-title":"AMPK signaling pathway is rapidly activated by T3 and regulates the cardiomyocyte growth","volume":"376","author":"Takano","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0675","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.yjmcc.2014.04.005","article-title":"Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells","volume":"72","author":"Yang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0680","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-025-00394-2","article-title":"Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction","volume":"10","author":"Bois","year":"2025","journal-title":"npj Regener Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0685","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bbadis.2014.11.003","article-title":"Sarcomeric protein isoform transitions in cardiac muscle: a journey to heart failure","volume":"1852","author":"Yin","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0690","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313023","article-title":"Alternative splicing in the heart: the therapeutic potential of regulating the regulators","volume":"25","author":"Briganti","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0695","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/01.RES.84.11.1310","article-title":"Effects of myosin heavy chain isoform switching on Ca2+\u2212activated tension development in single adult cardiac myocytes","volume":"84","author":"Metzger","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0700","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1006\/bbrc.1996.1267","article-title":"Alternative RNA splicing-generated cardiac troponin T isoform switching: a non-heart-restricted genetic programming synchronized in developing cardiac and skeletal muscles","volume":"225","author":"Jin","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0705","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1113\/JP283792","article-title":"Adapting to a new environment: postnatal maturation of the human cardiomyocyte","volume":"601","author":"Salameh","year":"2023","journal-title":"J Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0710","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/s41467-025-56384-x","article-title":"Cardiac repair using regenerating neonatal heart tissue-derived extracellular vesicles","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0715","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/CIRCHEARTFAILURE.114.001193","article-title":"Epigenetic mechanisms in heart failure pathogenesis","volume":"7","author":"Di Salvo","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0720","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cardiores.2004.01.021","article-title":"Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs","volume":"63","author":"Molkentin","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0725","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jjcc.2023.04.017","article-title":"The mechanism of the NFAT transcription factor family involved in oxidative stress response","volume":"83","author":"Zhang","year":"2024","journal-title":"J Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0730","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"A calcineurin-dependent transcriptional pathway for cardiac hypertrophy","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0735","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI118166","article-title":"Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium","volume":"96","author":"Knowlton","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0740","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91068","article-title":"Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface","volume":"2","author":"Wei","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0745","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","article-title":"Extracellular matrix remodeling and cardiac fibrosis","volume":"68\u201369","author":"Li","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0750","doi-asserted-by":"crossref","first-page":"eadv9157","DOI":"10.1126\/science.adv9157","article-title":"Preventing hypocontractility-induced fibroblast expansion alleviates dilated cardiomyopathy","volume":"390","author":"Bretherton","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0755","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.121.057763","article-title":"Defining the fetal gene program at single-cell resolution in pediatric dilated cardiomyopathy","volume":"146","author":"Mehdiabadi","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111400","article-title":"Genome-wide fetalization of enhancer architecture in heart disease","volume":"40","author":"Spurrell","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0765","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/01.RES.63.4.779","article-title":"Effects of acidosis on ventricular muscle from adult and neonatal rats","volume":"63","author":"Solaro","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0770","first-page":"278","article-title":"Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction","volume":"16","author":"Westfall","year":"2001","journal-title":"Physiology (Bethesda)"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0775","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2005.06.014","article-title":"A switch that lowers the betaAR: insights from a troponin I mutation linked to hypertrophic cardiomyopathy","volume":"40","author":"Westfall","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0780","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1172\/JCI24351","article-title":"Genetic causes of human heart failure","volume":"115","author":"Morita","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0785","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jacc.2014.10.069","article-title":"Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period","volume":"65","author":"Cannon","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0790","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/procel\/pwae032","article-title":"Integrative analysis of transcriptome, DNA methylome, and chromatin accessibility reveals candidate therapeutic targets in hypertrophic cardiomyopathy","volume":"15","author":"Gao","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0795","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41421-022-00490-3","article-title":"Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics","volume":"9","author":"Liu","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0800","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184309","article-title":"A ratiometric catalog of protein isoform shifts in the cardiac fetal gene program","volume":"10","author":"Han","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0805","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0810","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1536\/ihj.21.485","article-title":"Effect of verapamil on retrograde ventriculo-atrial conduction in children","volume":"21","author":"Kashani","year":"1980","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0815","article-title":"Electrophysiologic effects of verapamil in children","volume":"20","author":"Shakibi","year":"1979","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0820","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.athoracsur.2012.08.011","article-title":"Outcome of septal Myectomy for obstructive hypertrophic cardiomyopathy in children and Young adults","volume":"95","author":"Altarabsheh","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0825","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63703","article-title":"To lie or not to lie: super-relaxing with myosins","volume":"10","author":"Nag","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0830","doi-asserted-by":"crossref","first-page":"11731","DOI":"10.1073\/pnas.1821660116","article-title":"Cardiac myosin binding protein-C phosphorylation regulates the super-relaxed state of myosin","volume":"116","author":"McNamara","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180064","article-title":"MYBPC3 mutations are associated with a reduced super-relaxed state in patients with hypertrophic cardiomyopathy","volume":"12","author":"McNamara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0840","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012614","article-title":"Heterogeneous dysregulation of myosin super-relaxation and energetics in hypertrophic cardiomyopathy","volume":"18","author":"Ochala","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0845","doi-asserted-by":"crossref","first-page":"22501","DOI":"10.1038\/s41598-022-26889-2","article-title":"Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy","volume":"12","author":"Margara","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0850","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/s41467-024-47587-9","article-title":"Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite opposite effects in heart contraction","volume":"15","author":"Auguin","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0855","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/CIR.0000000000001151","article-title":"Treatment strategies for cardiomyopathy in children: a scientific statement from the American Heart Association","volume":"148","author":"Bogle","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0860","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010687","article-title":"Targeted therapies in pediatric and adult patients with hypertrophic heart disease: from molecular pathophysiology to personalized medicine","volume":"16","author":"Monda","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0865","article-title":"Myosin inhibitor reverses hypertrophic cardiomyopathy in genotypically diverse pediatric iPSC-cardiomyocytes to mirror variant correction","volume":"5","author":"Kinnear","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2025.107283","article-title":"Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial","volume":"292","author":"Rossano","year":"2026","journal-title":"Am Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0875","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/CIRCRESAHA.116.302752","article-title":"Molecular regulation of cardiomyocyte differentiation","volume":"116","author":"Paige","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0880","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13287-023-03448-8","article-title":"Ethical, legal, regulatory, and policy issues concerning embryoids: a systematic review of the literature","volume":"14","author":"Iltis","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0885","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/humrep\/deae228","article-title":"Ethical considerations on the moral status of the embryo and embryo-like structures","volume":"39","author":"Writing Group of the ESHRE Ethics Committee","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0890","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacbts.2024.10.017","article-title":"Experimental models of hypertrophic cardiomyopathy: a systematic review","volume":"10","author":"van den Dolder","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0895","doi-asserted-by":"crossref","first-page":"24057","DOI":"10.1074\/jbc.M704574200","article-title":"Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart","volume":"282","author":"Krenz","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0900","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1073\/pnas.86.10.3504","article-title":"Characterization of human cardiac myosin heavy chain genes","volume":"86","author":"Yamauchi-Takihara","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0905","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41592-024-02480-7","article-title":"Induced pluripotent stem cell-derived cardiomyocyte in vitro models: benchmarking progress and ongoing challenges","volume":"22","author":"Ewoldt","year":"2025","journal-title":"Nat Methods"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.10.001","article-title":"Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment","volume":"138","author":"Huang","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0915","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1155\/2019\/8203950","article-title":"Unchain my heart: integrins at the basis of iPSC cardiomyocyte differentiation","volume":"2019","author":"Santoro","year":"2019","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0920","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1030920","article-title":"Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: the impact of full-length dystrophin deficiency","volume":"13","author":"Pioner","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24129995","article-title":"The utilisation of hydrogels for iPSC-cardiomyocyte research","volume":"24","author":"Patel","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0930","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13287-021-02252-6","article-title":"Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes","volume":"12","author":"Garbern","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0935","doi-asserted-by":"crossref","first-page":"19090","DOI":"10.1074\/jbc.M109.007021","article-title":"A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy","volume":"284","author":"Pinto","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0940","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/CIRCHEARTFAILURE.111.961474","article-title":"Impaired mitochondrial biogenesis precedes heart failure in right ventricular hypertrophy in congenital heart disease","volume":"4","author":"Karamanlidis","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0945","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00109-013-1059-4","article-title":"A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension","volume":"91","author":"Sutendra","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0950","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-018-05362-7","article-title":"Glucose promotes cell growth by suppressing branched-chain amino acid degradation","volume":"9","author":"Shao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0955","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.7150\/thno.44146","article-title":"Retinoic acid promotes metabolic maturation of human embryonic stem cell-derived cardiomyocytes","volume":"10","author":"Miao","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0960","article-title":"The forgotten ventricle-right ventricular remodeling across pregnancy and postpartum: a report of original research","volume":"4","author":"Ambia","year":"2024","journal-title":"AJOG Glob Rep"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0965","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13052-021-01145-x","article-title":"Hypertrophic cardiomyopathy in infant newborns of diabetic mother: a heterogeneous condition, the importance of anamnesis, physical examination and follow-up","volume":"47","author":"Codazzi","year":"2021","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0970","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/hrt.63.5.308","article-title":"Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass","volume":"63","author":"Maron","year":"1990","journal-title":"Br Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0975","first-page":"e47","article-title":"Evaluation of left ventricular function, rotation, twist and untwist in patients with hypertrophic cardiomyopathy","volume":"18","author":"He","year":"2013","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0980","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/ehjci\/jead074","article-title":"Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis","volume":"24","author":"Ashkir","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0985","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10974-019-09545-7","article-title":"Cardiomyocyte nuclearity and ploidy: when is double trouble?","volume":"41","author":"Landim-Vieira","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0990","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jss.2019.05.048","article-title":"Right ventricular involution: big changes in small hearts","volume":"243","author":"Bowen","year":"2019","journal-title":"J Surg Res"},{"key":"10.1016\/j.jmccpl.2026.100859_bb0995","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024220","article-title":"Pediatric hypertrophic cardiomyopathy: exploring the genotype-phenotype association","volume":"11","author":"Nguyen","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1000","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.632293","article-title":"Hypertrophic cardiomyopathy in children: pathophysiology, diagnosis, and treatment of non-sarcomeric causes","volume":"9","author":"Monda","year":"2021","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1005","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1172\/JCI0214571","article-title":"Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy","volume":"109","author":"Arad","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jtcvs.2007.10.088","article-title":"Structure and function relationships of the helical ventricular myocardial band","volume":"136","author":"Buckberg","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1015","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejcts.2005.06.043","article-title":"The anatomical arrangement of the myocardial cells making up the ventricular mass","volume":"28","author":"Anderson","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1020","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag095","article-title":"Senescence-related myocardial dysfunction: keeping a young heart","author":"Ajjan","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1025","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.carpath.2017.06.012","article-title":"Ultrastructural aspects of vacuolar degeneration of cardiomyocytes in human endomyocardial biopsies","volume":"30","author":"Takemura","year":"2017","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1054-8807(03)00036-X","article-title":"Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy: a study of 204 cases (1996\u20132000)","volume":"12","author":"Lamke","year":"2003","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007849","article-title":"Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy","volume":"14","author":"Shimada","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1045","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jacc.2015.10.093","article-title":"Biallelic truncating mutations in ALPK3 cause severe pediatric cardiomyopathy","volume":"67","author":"Almomani","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1050","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ahj.2020.03.023","article-title":"Expanding the clinical and genetic spectrum of ALPK3 variants: phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants","volume":"225","author":"Herkert","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1055","doi-asserted-by":"crossref","DOI":"10.1007\/s10237-025-02003-z","article-title":"A computational model-based study on the mechano-energetic characteristics of the left ventricle with obstructive hypertrophic cardiomyopathy before and after septal myectomy","author":"Liu","year":"2025","journal-title":"Biomech Model Mechanobiol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1060","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/CIRCULATIONAHA.121.053755","article-title":"Loss of mitochondrial Ca2+ uniporter limits inotropic reserve and provides trigger and substrate for arrhythmias in Barth syndrome cardiomyopathy","volume":"144","author":"Bertero","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.828549","article-title":"Transcription factors involved in the development and prognosis of cardiac remodeling","volume":"13","author":"Hong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jmccpl.2026.100859_bb1075","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108499","article-title":"Modeling cardiomyocyte signaling and metabolism predicts genotype-to-phenotype mechanisms in hypertrophic cardiomyopathy","volume":"175","author":"Khalilimeybodi","year":"2024","journal-title":"Comput Biol Med"}],"container-title":["Journal of Molecular and Cellular Cardiology Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772976126000267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:43:22Z","timestamp":1789627402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772976126000267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":215,"alternative-id":["S2772976126000267"],"URL":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100859","relation":{},"ISSN":["2772-9761"],"issn-type":[{"value":"2772-9761","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immature and mature myocardium in the pathophysiology of hypertrophic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmccpl.2026.100859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100859"}}